Verastem (VSTM) Times Interest Earned (2017 - 2026)
Verastem (VSTM) posted quarterly Times Interest Earned of -$52.51 for Q1 2026, down 41.7% year-over-year from -$90.07 in Q1 2025, and up 47.46% quarter-over-quarter from -$99.94 in Q4 2025.
Powered by 
Analysis
Verastem (VSTM) Times Interest Earned (2017 - 2026) Analysis & Trends
Verastem's Times Interest Earned history runs 16 years deep, the most recent figure standing at -$52.51 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 41.7% year-over-year to -$52.51; the TTM figure through Mar 2026 stood at -$199.83 (down 81.73% YoY), while the FY2025 annual figure was -$26.73, down 6.09% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$52.51, up from -$99.94 in the prior quarter.
- The five-year high for Times Interest Earned was -$3.98 in Q2 2025, with the low at -$99.94 in Q4 2025.
- The 5-year median for Times Interest Earned is -$25.15 (2023), against an average of -$30.57.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned plunged 3861.11% in 2022, then jumped 75.43% in 2024.
- Verastem's Times Interest Earned stood at -$23.27 in 2022, then fell by 19.49% to -$27.8 in 2023, then gained by 0.85% to -$27.57 in 2024, then slumped by 262.55% to -$99.94 in 2025, then surged by 47.46% to -$52.51 in 2026.
- Business Quant data shows VSTM's Times Interest Earned at -$52.51 in Q1 2026, -$99.94 in Q4 2025, and -$8.58 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn | -90.86 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -90.86 |
| Mar 31, 2026 | -117.53 |
| Dec 31, 2025 | -99.94 |
| Sep 30, 2025 | -127.63 |
| Jun 30, 2025 | -206.43 |
| Mar 31, 2025 | -230.07 |
| Dec 31, 2024 | -27.57 |
| Sep 30, 2024 | -32.26 |
| Jun 30, 2024 | -16.06 |
| Mar 31, 2024 | -24.83 |
| Dec 31, 2023 | -27.80 |
| Sep 30, 2023 | -18.87 |
| Jun 30, 2023 | -18.10 |
| Mar 31, 2023 | -25.15 |
| Dec 31, 2022 | -23.27 |
| Sep 30, 2022 | -24.70 |
| Jun 30, 2022 | -33.44 |
| Mar 31, 2022 | -303.21 |
| Dec 31, 2021 | -1,651.10 |
| Sep 30, 2021 | -1.86 |